M. Taylor

发表

Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR

A. Harris, Y. Lo, Cheng Han, 2004, British Journal of Cancer.

A phase II study of mitomycin C and oral etoposide for advanced adenocarcinoma of the upper gastrointestinal tract.

A. Harris, K. O'Byrne, T. Ganesan, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Standard dose (Mayo regimen) 5-fluorouracil and low dose folinic acid: prohibitive toxicity?

L. Stitt, M. Sawyer, E. Winquist, 2000, American journal of clinical oncology.

A phase II study of the modulation of 5-fluorouracil and folinic acid with high-dose infusional hydroxyurea in metastatic colorectal carcinoma.

A. Harris, P. Philip, K. O'Byrne, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Preoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancer.

L. Stitt, G. Bauman, M. Vincent, 1998, International journal of radiation oncology, biology, physics.

Association of ARNT splice variants with estrogen receptor-negative breast cancer, poor induction of vascular endothelial growth factor under hypoxia, and poor prognosis.

A. Harris, S. Safe, C. Blancher, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer

A. Harris, A. Blann, D. Talbot, 2011, British Journal of Cancer.

Thymidylate Synthase Expression in Stage II and III Colon Cancer: A Retrospective Review

C. Earle, L. Stitt, P. Johnston, 2001, American journal of clinical oncology.

Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer.

F. Shepherd, Y. Cormier, R. Feld, 1997, Seminars in oncology.

Analysis of the clinical benefit of 5-fluorouracil and radiation treatment in locally advanced pancreatic cancer.

G. Bauman, M. Vincent, A. Tomiak, 1999, International journal of radiation oncology, biology, physics.

Cyclophosphamide, methotrexate and infusional 5-fluorouracil (infusional CMF) in metastatic breast cancer.

A. Harris, K. O'Byrne, T. Ganesan, 1998, British Journal of Cancer.

Short report A phase II study of the modulation of 5-fluorouracil and folinic acid with high-dose infusional hydroxyurea in metastatic colorectal carcinoma

K., D. Talbot, D., 2005 .

Induction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid and interferon alpha

A. Harris, K. O'Byrne, T. Ganesan, 2000, British Journal of Cancer.

A phase I pilot study of pelvic radiation and alpha-2A interferon in patients with locally advanced or recurrent rectal cancer.

B. Fisher, M. Vincent, F. Perera, 1997, International journal of radiation oncology, biology, physics.

The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis

J. Ragoussis, A. Harris, C. West, 2011, British Journal of Cancer.

Phase I study of the novel cyclic AMP (cAMP) analogue 8-chloro-cAMP in patients with cancer: toxicity, hormonal, and immunological effects.

M. Dowsett, A. Harris, K. O'Byrne, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Upregulation of basic fibroblast growth factor in breast carcinoma and its relationship to vascular density, oestrogen receptor, epidermal growth factor receptor and survival.

S. Fox, A. Harris, M. Greenall, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Relationship of vascular maturation in breast cancer blood vessels to vascular density and metastasis, assessed by expression of a novel basement membrane component, LH39

S. Fox, A. Harris, A. Giatromanolaki, 2000, British Journal of Cancer.

Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status.

D. Schultz, F. Vicini, L. Pierce, 2001, International journal of radiation oncology, biology, physics.

Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast.

D. Schultz, A. Recht, B. Fowble, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast.

D. Schultz, A. Recht, B. Fowble, 1994, International journal of radiation oncology, biology, physics.

A Randomized Phase II Trial of First-Line Treatment with Gemcitabine, Erlotinib, or Gemcitabine and Erlotinib in Elderly Patients (Age (cid:1) 70 Years) with Stage IIIB/IV Non-small Cell Lung Cancer

M. Socinski, J. Beaumont, A. Peterman, 2011 .

COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatment

S. Fox, A. Harris, D. Generali, 2014, British Journal of Cancer.

An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom

A. Harris, A. Gray, H. Campbell, 2009, British Journal of Cancer.

Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK

A. Harris, A. Briggs, A. Gray, 2010, British Journal of Cancer.

A prospective clinical utility and pharmacoeconomic study of the impact of the 21-gene Recurrence Score® assay in oestrogen receptor positive node negative breast cancer.

K. Gelmon, S. Peacock, C. Lohrisch, 2013, European journal of cancer.

Human AP endonuclease 1 (HAP1) protein expression in breast cancer correlates with lymph node status and angiogenesis.

S. Fox, A. Harris, K. Engels, 1998, British Journal of Cancer.

Comparison of prognostic factors in patients in phase I trials of cytotoxic drugs vs new noncytotoxic agents

A. Harris, T. Ganesan, J. Braybrooke, 2003, British Journal of Cancer.

Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer

A. Blann, D. Talbot, D. Talbot, 2011, British Journal of Cancer.